---
$id: https://graph.org.ai/products/commodity/51141578
$type: Product
source: UNSPSC
code: "51141578"
title: "Rufinamide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rufinamide

**UNSPSC Code**: 51141578
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C10H8F2N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WFW942PR79, chemically known as 1h-1,2,3-triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)- but generally known as rufinamide, which bears US NIH Compound Identifier 129228. European Medicines Agency schedules Rufinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10403MIG. The term RUFINAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules rufinamide in its Anatomical Therapeutic Chemical (ATC) Classification. RUFINAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rufinamide under HS 29339990 and SITC 51577. As of Q4 2014, RUFINAMIDE remains the US FDA Preferred Term for this commodity. Rufinamide bears US NLM identifiers UMLS ID C0213404 and NCI Concept Code C75167. SMILES: C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F.

